Home › Funds › Cormorant Asset Management, LP › JBIO

Cormorant Asset Management, LP position in JBIO

JADE BIOSCIENCES INC · Health Care

Cormorant Asset Management, LP reported holding 300,000 shares of JBIO (JADE BIOSCIENCES INC) in its Q3 2026 13F filing — a position valued at US$4.2M, representing 0.30% of its reported portfolio and ranking #41 among its reported holdings. Cormorant Asset Management, LP first reported this position in Q3 2026.

Latest position (Q3 2026)300.00K sh
Reported value held$4.21M
Portfolio Weight0.30%
First reportedQ3 2026
Last changeNew
Updated2026-11-17

Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR

How Cormorant Asset Management, LP's JBIO position evolved

Cormorant Asset Management, LP first disclosed a stake in JBIO in Q3 2026 at 300,000 shares (US$4.2M).

Quarter by quarter

QuarterSharesValueChange
Q3 2026 300.00K $4.21M New

About JBIO and 13F data

JBIO (JADE BIOSCIENCES INC) is a Health Care company. 81 other funds we track also report a position in JBIO — the largest reported positions include Paradigm Biocapital Advisors LP (US$85.0M), Fairmount Funds Management LLC (US$64.0M), Bellevue Group AG (US$60.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding JBIO

All JBIO fund holders →

FAQ

How long has Cormorant Asset Management, LP held JBIO?

Cormorant Asset Management, LP has disclosed JBIO holdings in 1 of the last 1 reported quarters, going back to Q3 2026.

What is Cormorant Asset Management, LP's current position in JBIO?

As of Q3 2026, Cormorant Asset Management, LP holds 300.00K shares of JBIO (JADE BIOSCIENCES INC), valued at $4.21M, representing 0.30% of its reported portfolio and ranking #41.

Has Cormorant Asset Management, LP been buying or selling JBIO?

In the latest 13F filing (Q3 2026), Cormorant Asset Management, LP newly opened its position in JBIO.

Which other funds hold JBIO?

Other major institutional holders of JBIO include Paradigm Biocapital Advisors LP, Fairmount Funds Management LLC, Bellevue Group AG, among 81 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.